The Economic Impact of Preservation Time in Cadaveric Liver Transplantation

American Journal of Transplantation

Volumn 1, Issue 4, 2001, Pages 360-365

  Schnitzler, Mark A ^a   Woodward, Robert S ^a   Brennan, Daniel C ^a   Whiting, James F ^b   Tesi, Raymond J ^c   Lowell, Jeffrey A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

Cold ischemia time; Cost; Organ allocation

Indexed keywords

ARTICLE; BODY CONSTITUTION; CHILD; CLINICAL TRIAL; COST; DONOR; ECONOMICS; FACTUAL DATABASE; FEMALE; HEALTH CARE ORGANIZATION; HOSPITALIZATION; HUMAN; LIVER TRANSPLANTATION; MALE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; ORGAN PRESERVATION; PHYSIOLOGY; RACE; REOPERATION; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

BODY CONSTITUTION; CHILD; CONTINENTAL POPULATION GROUPS; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; LIVER TRANSPLANTATION; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); ORGAN PRESERVATION; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 0035502428     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2001.10412.x     Document Type: Article

References (27)

1. Starzl TE, Groth CG, Brettschneider L et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968; 168: 392-415.
2. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 329: 1092-1099.
3. US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant Data: 1988-98. Richmond, VA: UNOS; and Rockville, MD: Division of Transplantation. Office of Special Programs, Health Resources and Services Administration, US Department of Health and Human Services.
4. Schulger LK, Miller CM. In support of the HHS regulations on organ allocation. Graft 1999; 2: 48-52.
5. Kalayoglu M, Sollinger WH, Stratta RJ et al. Extended preservation of the liver for clinical transplantation. Lancet 1988; 1: 617-619.
6. Todo S, Nery J, Yanaga K, Podesta L, Gordon RD, Starzl TE. Extended preservation of human liver grafts with UW solution. J Am Med Assoc 1989; 261: 711-714.
7. Furukawa H, Todo S, Imventarza O et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51: 1000-1004.
8. Scotte M, Dousset B, Calmus Y, Conti F, Houssin D, Chapuis Y. The influence of cold ischemia time on biliary complications following liver transplantation. J Hepatol 1994; 21: 340-346.
9. Carrasco L, Sanchez-Bueno F, Sola J et al. Effects of cold ischemia time on the graft after orthotopic liver transplantation: a bile cytological study. Transplantation 1996; 61: 393-396.
10. Janny S, Sauvanet A, Farges O et al. Outcome of liver grafts with more than 10 hours of cold ischemia. Transplant Proc 1997; 29: 2346-2347.
11. Klar E, Angelescu M, Zapletal C, Kraus T, Bredt M, Herfarth C. Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. Transplant Proc 1998; 30: 3683-3685.
12. Adam R, Bismuth H, Diamond T et al. Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 1992; 340: 1373-1376.
13. Detre KM. The NIDDK Liver Transplantation Database. In: Teresaki P, ed. Clinical Transplants, 1986. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1986, 29-33.
14. Showstack J, Katz PP, Lake JR et al. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. J Am Med Assoc 1999; 281: 1381-1386.
15. Wei YL, Detre KM, Evehart JE and the NIDDK Liver Transplantation Database. The NIDDK Liver Transplantation Database. Liver Transpl Surg 1997; 3: 10-22.
16. Judge GG, Hill RC, Griffiths WE, Lutkepohl H, Lee TC. Introduction to the Theory and Practice of Econometrics, 2nd edn. New York, NY: John Wiley; 1988, 838-850.
17. Efron B. The Jackknife, the Bootstrap, and Other Resampling Plans. Philadelphia: Society for Industrial and Applied Mathematics; 1982.
18. Schnitzler MA, Hollenbeak CS, Cohen DS et al. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med 1999; 341: 1440-1446.
19. Deschenes M, Belle SH, Krom RAF, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation. Transplantation 1998; 66: 302-310.
20. Chari RS, baker ME, Sue. SR, Meyers WC. Regeneration of a transplanted liver after right hepatic lobectomy. Liver Transplant Surg 1996; 2: 233-234.
21. Federal Register. 42 CFR Part 121: Organ procurement and transplantation: final rule. April 2, 1998. UCLA Tissue Typing Laboratory, Los Angeles, CA: 1998, 16295-16338.
22. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
23. Muhlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc 1999; 31: 2069-2070.
24. DeCarlis L, Sansalone CV, Rondinara GF et al. Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria. Transpl Int 1996; 9: S414-417.
25. Alexander JW, Zola JC. Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant 1996; 10: 1-19.
26. World Health Organization. Guiding principles on human organ transplantation. Lancet 1991; 337: 1470-1471.
27. Council for Ethical and Judicial Affairs, American Medical Association. Ethical demand for liver transplantation. Clin Transplant 1997; 11: 49-55.